The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
More than 10,000 scientific publications containing EUDRAGIT
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Subscribe To Our Newsletter & Stay Updated
